Eli Lilly is a safer way to capitalize on AI-driven drug discovery.

Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today its CEO & President, Najat Khan, Ph.D., will present Tuesday, January 13 ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Nkembuh, N. (2026) Symbiotic Communication Systems: Examining the Co-Evolution of Human-AI Communication Patterns in the ...

Author Shawn Peters blends clarity and rigor to make data structures and algorithms accessible to all learners. COLORADO, CO, UNITED STATES, January 2, 2026 /EINPresswire.com/ — Vibrant Publishers ...

A new research paper reframes the simulation hypothesis, asking whether reality could be simulated and what science can test.

其核心思想是借鉴计算机科学中的“外存算法” (Out-of-core algorithms)，不要把长 Prompt 直接喂给神经网络，而是把它放在一个外部的 Python REPL 环境里。 Prompt 被加载为环境中的变量context 。模型不再像以前那样生吞整个字符串，而是通过编写代码（如len (context) , context.split , re.search ）来按需读取数据 ...

新年伊始，MIT CSAIL 的一纸论文在学术圈引发了不小的讨论。Alex L． Zhang 、 Tim Kraska 与 Omar Khattab 三位研究者在 arXiv 上发布了一篇题为《Recursive Language ...

With over 18,000 tokens tracked across centralized and decentralized exchanges, the entire crypto market is worth nearly $3 trillion. This is 31% lower from the all-time high of $4.37 trillion in ...